fbpx Skip to main content

BioCommunique Article

Bringing you the latest financial and strategic news from top leaders in life science.

Mammoth Biosciences’ Study Validates Use of COVID-19 Testing Method; Dexcom Receives FDA Permission to Use Continuous Glucose Monitors on COVID-19 Patients; Arcturus Announces Clinical Trial Timeline for COVID-19 Vaccine

  • 2020-04-16T20:45:00.000+0000
  • California
  • Author: Lauren Panetta

4/16/20 – TechCrunch
Mammoth Biosciences receives first peer-reviewed validation of CRISPR-based COVID-19 test

4/15/20 – Histogen
Histogen Publishes New Preclinical Data on its HST 003 Orthopedic Program

4/15/20 – The San Diego Union-Tribune
Dexcom gets FDA permission to use continuous glucose monitors on hospitalized COVID-19 patients

4/15/20 – Aligos Therapeutics
Aligos Therapeutics Expands Licensing Agreement with Luxna Biotech in Oligonucleotide Technology to Include Novel Coronavirus Targets

4/15/20 – FiercePharma
Novo Nordisk expands 90-day free insulin program to workers affected by COVID-19

4/15/20 – Ansun Biopharma
Ansun Biopharma Enrolls First Patient in Proof of Concept Trial of DAS181 for the Treatment of COVID-19

4/14/20 – NBC San Diego
Inovio Exec Puts All Efforts on COVID-19 Solutions

4/13/20 – UC San Diego
Conrad Prebys Foundation Awards $350,000 Challenge Grant to Support UC San Diego’s COVID-19 Efforts

4/11/20 – KPBS
La Jolla Institute Leading Global Hunt For Antibodies To Coronavirus

4/9/20 – BioPharma Dive
Myokardia at inflection point as heart drug readout nears

4/9/20 – Arcturus Therapeutics
Arcturus Therapeutics Announces Clinical Trial Timeline for its COVID-19 Vaccine

4/9/20 – Samsung Biologics; Vir Biotechnology
Samsung Biologics and Vir Biotechnology Enter into Agreement for Large Scale Manufacture of SARS-COV-2 Antibodies for Potential COVID-19 Treatment

4/8/20 – Ionis
Ionis establishes $25,000 scholarship to help ALS patients in greater San Diego area participate in physical and mental wellness programs

4/7/20 – Scientist.com
Scientist.com Recognized as One of The Americas’ Fastest Growing Companies by The Financial Times

4/6/20 – 23andMe
23andMe Engages Its Millions of Research Participants to Study COVID-19

3/30/20 – FierceBiotech
GigaGen jumps into COVID-19 arena with polyclonal antibodies

3/22/20 – City of Berkeley Mayor's Office
Berkeley Relief Fund Receives $250,000 Donation from Bayer as Virtual Fundraiser Starts